Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Hoffmann-La Roche
Eli Lilly and Company
Cancer Research UK
Eli Lilly and Company
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
Cancer Research UK
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Poseida Therapeutics, Inc.
Atara Biotherapeutics
Taipei Veterans General Hospital, Taiwan
Hoffmann-La Roche
Revolution Medicines, Inc.
Daiichi Sankyo
Rigshospitalet, Denmark